Pending EO 12866 Regulatory Review

RIN: 0910-ZC01	Received Date: 07/09/2024
Title: Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability
Agency/Subagency: HHS / FDA	Stage: Notice
Legal Deadline: Statutory	Section 3(f)(1) Significant: No
International Impacts: Yes	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No